Mengke Chen

493 total citations
30 papers, 322 citations indexed

About

Mengke Chen is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Mengke Chen has authored 30 papers receiving a total of 322 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Organic Chemistry. Recurrent topics in Mengke Chen's work include Epigenetics and DNA Methylation (6 papers), Polyoxometalates: Synthesis and Applications (4 papers) and Ferroptosis and cancer prognosis (4 papers). Mengke Chen is often cited by papers focused on Epigenetics and DNA Methylation (6 papers), Polyoxometalates: Synthesis and Applications (4 papers) and Ferroptosis and cancer prognosis (4 papers). Mengke Chen collaborates with scholars based in China, United States and Hong Kong. Mengke Chen's co-authors include Zaihui Fu, Yachun Liu, Bo Yang, Chao Zhang, Chao Zhang, Senpei Tang, Rengyun Liu, Ye Sang, Haipeng Xiao and Yanfeng Ouyang and has published in prestigious journals such as The Science of The Total Environment, Applied Catalysis B: Environmental and Scientific Reports.

In The Last Decade

Mengke Chen

25 papers receiving 319 citations

Peers

Countries citing papers authored by Mengke Chen

Since Specialization

Citations

This map shows the geographic impact of Mengke Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengke Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengke Chen more than expected).

Fields of papers citing papers by Mengke Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mengke Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengke Chen. The network helps show where Mengke Chen may publish in the future.

Co-authorship network of co-authors of Mengke Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Mengke Chen. A scholar is included among the top collaborators of Mengke Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mengke Chen. Mengke Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Association between oxidative balance score and all-cause and cancer-specific mortality among cancer survivors 2025 ·Frontiers in Immunology ·(unknown), (unknown), Mengke Chen, Rong Xia, Qi Zhang	1
2	Dietary inflammatory index and depressive symptoms as mediators between social disadvantage and accelerated phenotypic aging 2025 ·Journal of Affective Disorders ·Mengke Chen, (unknown), (unknown), Jun Zhang, Rong Xia, (unknown)	0
3	Risk stratification by combining common genetic mutations and TERT promoter methylation in papillary thyroid cancer 2024 ·Endocrine ·Ye Sang, Guanghui Hu, (unknown), Mengke Chen, Shubin Hong, Rengyun Liu	6
4	The ERK inhibitor GDC-0994 selectively inhibits growth of BRAF mutant cancer cells 2024 ·Translational Oncology ·(unknown), Ye Sang, (unknown), (unknown), Mengke Chen, Shubin Hong, Weiming Lv, Kartik Sehgal, Haipeng Xiao, Rengyun Liu	6
5	Towards precision oncology discovery: four less known genes and their unknown interactions as highest-performed biomarkers for colorectal cancer 2024 ·npj Precision Oncology ·Yongjun Liu, Yuqing Xu, Xiaoxing Li, Mengke Chen, Xueqin Wang, Ning Zhang, Heping Zhang, Zhengjun Zhang	3
6	SPATS2L is a positive feedback regulator of the type I interferon signaling pathway and plays a vital role in lupus 2024 ·Acta Biochimica et Biophysica Sinica ·Mengke Chen, Yutong Zhang, (unknown), Xuejiao Song, Yue Yang, Guojun Hou, Huihua Ding, Sheng Chen, Wanling Yang, Nan Shen, Yong Cui, Xianbo Zuo, Yuanjia Tang	0
7	Screening of cellulose-degrading bacteria and its degradation and growth-promoting applications 2024 ·Journal of Industrial Microbiology & Biotechnology ·Mengke Chen, Xuebin Li, (unknown), (unknown), (unknown)	1
8	The activation of mTOR signalling modulates DNA methylation by enhancing DNMT1 translation in hepatocellular carcinoma 2023 ·Journal of Translational Medicine ·Mengke Chen, Y. Q. Fang, (unknown), Ning Zhang, Xinyue Zhang, Lixia Xu, Xuxin Ren, Qingfeng Zhang, Yufeng Zhou, Sui Peng, Jun Yu, Judeng Zeng, Xiaoxing Li	14
9	Methylation-Mediated Silencing of ATF3 Promotes Thyroid Cancer Progression by Regulating Prognostic Genes in the MAPK and PI3K/AKT Pathways 2023 ·Thyroid ·(unknown), Mengke Chen, Ye Sang, (unknown), (unknown), Yulu Chen, Luyao Zhang, Shuang Yu, Weiming Lv, Yanbing Li, Rengyun Liu, Haipeng Xiao	18
10	Highly sensitive droplet digital PCR for detection of RET fusion in papillary thyroid cancer 2023 ·BMC Cancer ·Mengke Chen, (unknown), Ye Sang, Wenting Jiang, Weiman He, Shubin Hong, Weiming Lv, Haipeng Xiao, Rengyun Liu	1
11	EBV-encoded miRNAs BHRF1-1 and BART2-5p aggravate post- transplant lymphoproliferative disorder via LZTS2-PI3K-AKT axis 2023 ·Biochemical Pharmacology ·Hao Ji, Taihua Yang, Chunlai Li, Youwei Zhu, Zhigang Zheng, Jiaxu Zhang, Yuan Liu, Yijin Gao, Huimin Wu, (unknown), (unknown), Mengke Chen, Yuanjia Tang, Qiang Xia, Feng Xue	0
12	Integration of risk variants from GWAS with SARS-CoV-2 RNA interactome prioritizes FUBP1 and RAB2A as risk genes for COVID-19 2023 ·Scientific Reports ·(unknown), Mengke Chen, Tingting Pan, Mengjie Chen, (unknown), (unknown), Sheng Chen, Yuanjia Tang	2
13	RNF135 Promoter Methylation Is Associated With Immune Infiltration and Prognosis in Hepatocellular Carcinoma 2022 ·Frontiers in Oncology ·Xiao Wang, Mengke Chen, Liang Xiong, Yu Bai, Judeng Zeng, Xiaoyi Xu, Hao Li, Jing Wang, (unknown), Guijun Zhao	17
14	Occurrence, spatial heterogeneity, and risk assessment of perfluoroalkyl acids (PFAAs) in the major rivers of the Tibetan Plateau 2022 ·The Science of The Total Environment ·Jiao Ren, Mengjiao Yu, Feng Chen, Liang Cui, (unknown), Junming Li, Mengke Chen, Xiaoping Wang, Jianjie Fu	18
15	The ETS Inhibitor YK-4-279 Suppresses Thyroid Cancer Progression Independent of TERT Promoter Mutations 2021 ·Frontiers in Oncology ·(unknown), (unknown), Peijie Shi, Mengke Chen, Shuang Yu, Shubin Hong, Yanbing Li, Rengyun Liu, Haipeng Xiao	10
16	Design and Implementation of Zone-to-Zone Demand Responsive Transportation Systems 2021 ·Transportation Research Record Journal of the Transportation Research Board ·Shiyu Shen, Yanfeng Ouyang, (unknown), Mengke Chen, (unknown)	17
17	9,10-Dihydroanthracene auto-photooxidation efficiently triggered photo-catalytic oxidation of organic compounds by molecular oxygen under visible light 2020 ·Molecular Catalysis ·(unknown), Mengke Chen, (unknown), (unknown), (unknown), Bo Yang, (unknown), Chao Zhang, Yachun Liu, Zaihui Fu	13
18	Hybridizing Engineering Strategy of Decatungstate. 2. Regulated Effect of Doping Transition Metal Ions on Photocatalytic Oxidation Performance of (nBu₄N)₄W₁₀O₃₂ 2020 ·Inorganic Chemistry ·(unknown), Mengke Chen, Zaihui Fu, Bo Yang, (unknown), (unknown), Chao Zhang, Yachun Liu	20
19	Fibroblast growth factor 21 Ameliorates diabetes-induced endothelial dysfunction in mouse aorta via activation of the CaMKK2/AMPKα signaling pathway 2019 ·Cell Death and Disease ·Ying Lei, Na Li, (unknown), (unknown), Nan Yan, (unknown), (unknown), (unknown), Wei Lin, Xinyu Zhao, Lu Lu, Mengke Chen, Wei Cen, (unknown), Xiaokun Li, Zhifeng Huang, Yang Wang	44
20	IDDF2018-ABS-0140 The crosstalk of MTORC1 and DNA methylation in hepatocellular carcinoma 2018 ·Judeng Zeng, Mengke Chen, Ning Zhang, Lixia Xu, Yang Yang, Xiaoyi Xu, Hui‐Yun Wang, (unknown)	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact